Annual Total Liabilities
$17.07 M
+$6.32 M+58.78%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual total liabilities is currently $17.07 million, with the most recent change of +$6.32 million (+58.78%) on 31 December 2023. During the last 3 years, it has risen by +$6.47 million (+61.07%). ACRV annual total liabilities is now -86.91% below its all-time high of $130.40 million, reached on 31 December 2021.ACRV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$17.79 M
+$3.27 M+22.48%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly total liabilities is currently $17.79 million, with the most recent change of +$3.27 million (+22.48%) on 30 September 2024. Over the past year, it has increased by +$4.85 million (+37.46%). ACRV quarterly total liabilities is now -86.66% below its all-time high of $133.33 million, reached on 30 September 2022.ACRV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +58.8% | +37.5% |
| 3 y3 years | +61.1% | -86.4% |
| 5 y5 years | - | - |
ACRV Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -86.9% | +61.1% | -86.7% | +82.9% |
| 5 y | 5 years | -86.9% | +61.1% | -86.7% | +82.9% |
| alltime | all time | -86.9% | +61.1% | -86.7% | +82.9% |
Acrivon Therapeutics Common Stock Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $17.79 M(+22.5%) |
| June 2024 | - | $14.53 M(+15.8%) |
| Mar 2024 | - | $12.54 M(-26.5%) |
| Dec 2023 | $17.07 M | $17.07 M(+31.9%) |
| Sept 2023 | - | $12.94 M(+19.1%) |
| June 2023 | - | $10.87 M(+11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $9.73 M(-9.5%) |
| Dec 2022 | $10.75 M(-91.8%) | $10.75 M(-91.9%) |
| Sept 2022 | - | $133.33 M(+1.3%) |
| June 2022 | - | $131.57 M(+0.9%) |
| Dec 2021 | $130.40 M(+1130.4%) | - |
| Dec 2021 | - | $130.40 M |
| Dec 2020 | $10.60 M | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual total liabilities?
- What is the all time high annual total liabilities for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual total liabilities year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly total liabilities?
- What is the all time high quarterly total liabilities for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly total liabilities year-on-year change?
What is Acrivon Therapeutics Common Stock annual total liabilities?
The current annual total liabilities of ACRV is $17.07 M
What is the all time high annual total liabilities for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual total liabilities is $130.40 M
What is Acrivon Therapeutics Common Stock annual total liabilities year-on-year change?
Over the past year, ACRV annual total liabilities has changed by +$6.32 M (+58.78%)
What is Acrivon Therapeutics Common Stock quarterly total liabilities?
The current quarterly total liabilities of ACRV is $17.79 M
What is the all time high quarterly total liabilities for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly total liabilities is $133.33 M
What is Acrivon Therapeutics Common Stock quarterly total liabilities year-on-year change?
Over the past year, ACRV quarterly total liabilities has changed by +$4.85 M (+37.46%)